/////////// Investor Conference Call FY/Q4 2021 Results March 1, 2022 Werner Baumann, CEO Wolfgang Nickl, CFO Cautionary Statements Regarding Forward-Looking Information This presentation may contain forward-looking statements based on current assumptions and forecasts made by Bayer management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates ...

Bayer AG (OTCPK:BAYZF) Q4 2021 Earnings Conference Call March 1, 2022 8:00 AM ET Company Participants Oliver Maier - Head, IR Werner Baumann - Chairman, CEO & Chief Sustainability Officer Rodrigo Santos - President, the Crop Science Division Wolfgang Nickl - CFO Stefan Oelrich - Head, the Pharmaceuticals Division Heiko Schipper - President, the Consumer Health Division Conference Call Participants Vincent Andrews - Morgan Stanley Peter Verdult - Citigroup Michael Leuchten - UBS Sachin Jain - Bank of America ...

1 /// JP Morgan Healthcare Conference /// January 10-13, 2022 40th Annual J.P. Morgan Healthcare Conference January 10-13, 2022 /////////// Stefan Oelrich Member of the Board of Management of Bayer AG President of the Pharmaceuticals Division Cautionary statements regarding forward-looking information This presentation may contain forward-looking statements based on current assumptions and forecasts made by Bayer management. Various known and unknown risks, uncertainties and other factors could lead to mate ...

Bayer Aktiengesellschaft (OTCPK:BAYZF) Q3 2021 Earnings Conference Call November 9, 2021 8:00 AM ET Company Participants Oliver Maier - Head, Investor Relations Werner Baumann - Chief Executive Officer Wolfgang Nickl - Chief Financial Officer Stefan Oelrich - President, Pharmaceuticals Division Liam Condon - President, Crop Science Division Heiko Schipper - President, Consumer Health Conference Call Participants Michael Leuchten - UBS James Quigley - Morgan Stanley Joel Jackson - BMO Capital Markets Sachin ...

/////////// Investor Conference Call Q3 2021 Results November 9, 2021 Werner Baumann, CEO Wolfgang Nickl, CFO Cautionary Statements Regarding Forward-Looking Information This presentation may contain forward-looking statements based on current assumptions and forecasts made by Bayer management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates ...

Bayer Aktiengesellschaft (OTCPK:BAYZF) Q2 2021 Earnings Conference Call August 5, 2021 8:00 AM ET Company Participants Oliver Maier - Head-Investor Relations Werner Baumann - Chief Executive Officer Wolfgang Nickl - Chief Financial Officer Stefan Oelrich - President-Pharmaceuticals Division Liam Condon - President Crop Science Division Conference Call Participants Michael Leuchten – UBS Vincent Andrews – Morgan Stanley Joel Jackson – BMO Jo Walton – Credit Suisse James Quigley – Morgan Stanley Tony Jones – ...

| --- | --- | |------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | Half-Year | | | Financial Report 2021 | Bayer: Strong growth, guidance upgrade | | | // Group sales at €10.9 billion (Fx & p adj. +12.9%) -- double-digit percentage growth | | | (Fx & p adj.) at all divisions // EBITDA before special items at €2.6 billion (--10.6%), burdened by currency effects ...

Bayer Aktiengesellschaft (OTCPK:BAYZF) Q1 2021 Earnings Conference Call May 12, 2021 8:00 AM ET Company Participants Oliver Maier - Head of Investor Relations Werner Baumann - CEO Wolfgang Nickl - CFO Liam Condon - President, Crop Science Division Stefan Oelrich - Head, Pharmaceuticals Division Conference Call Participants Vincent Andrews - Morgan Stanley Peter Verdult - Citigroup Inc Joel Jackson - BMO Capital Markets Equity Research Christian Faitz - Kepler Cheuvreux Tony Jones - Redburn Laerke Engkilde - ...

/////////// Investor Conference Call Q1 2021 Results May 12, 2021 Werner Baumann, CEO Wolfgang Nickl, CFO RESTRICTED Cautionary Statements Regarding Forward-Looking Information This presentation may contain forward-looking statements based on current assumptions and forecasts made by Bayer management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the est ...